RAN Translation Regulated by Muscleblind Proteins in Myotonic Dystrophy Type 2

Tao Zu, John D. Cleary, Yuanjing Liu, Monica Bañez-Coronel, Jodi L. Bubenik, Fatma Ayhan, Tetsuo Ashizawa, Guangbin Xia, H. Brent Clark, Anthony T. Yachnis, Maurice S. Swanson, Laura P.W. Ranum

Research output: Contribution to journalArticlepeer-review

97 Scopus citations


Several microsatellite-expansion diseases are characterized by the accumulation of RNA foci and RAN proteins, raising the possibility of a mechanistic connection. We explored this question using myotonic dystrophy type 2, a multisystemic disease thought to be primarily caused by RNA gain-of-function effects. We demonstrate that the DM2 CCTG⋅CAGG expansion expresses sense and antisense tetrapeptide poly-(LPAC) and poly-(QAGR) RAN proteins, respectively. In DM2 autopsy brains, LPAC is found in neurons, astrocytes, and glia in gray matter, and antisense QAGR proteins accumulate within white matter. LPAC and QAGR proteins are toxic to cells independent of RNA gain of function. RNA foci and nuclear sequestration of CCUG transcripts by MBNL1 is inversely correlated with LPAC expression. These data suggest a model that involves nuclear retention of expansion RNAs by RNA-binding proteins (RBPs) and an acute phase in which expansion RNAs exceed RBP sequestration capacity, are exported to the cytoplasm, and undergo RAN translation. Video Abstract [Figure presented] Zu et al. show that the DM2 CCTG⋅CAGG expansion expresses sense and antisense poly-(LPAC) and poly-(QAGR) RAN proteins. Nuclear sequestration of CCUG transcripts by MBNL1 reduces poly-(LPAC) RAN proteins, and sequestration failure leads to upregulation of RAN proteins.

Original languageEnglish (US)
Pages (from-to)1292-1305.e5
Issue number6
StatePublished - Sep 13 2017

Bibliographical note

Funding Information:
We would like to thank myotonic dystrophy family members who contributed to this study, John Day and the Stanford Tissue Repository and the Center for NeuroGenetics at the University of Florida for autopsy tissue. This work was funded by the NIH NINDS PO1-NS058901 (L.P.W.R., M.S.S., and H.B.C.), the Muscular Dystrophy Association MDA218592 (L.P.W.R.), and a Postdoctoral Fellowship from the Myotonic Dystrophy Foundation MDF-FF-2009-0004 (J.D.C.). T.Z. and L.P.W.R. have patents pending on RAN translation. A.T.Y. receives partial support from the 1-Florida ADRC ( P50 AG047266-01A1 ).

Publisher Copyright:
© 2017 Elsevier Inc.


  • C9ORF72
  • DM
  • DM2
  • MBNL
  • RAN translation
  • RNA foci
  • muscleblind proteins
  • myotonic dystrophy
  • non-ATG translation
  • non-AUG initiation


Dive into the research topics of 'RAN Translation Regulated by Muscleblind Proteins in Myotonic Dystrophy Type 2'. Together they form a unique fingerprint.

Cite this